EU leaders have agreed to donate at least 100 million doses of COVID-19 vaccine to poorer nations by the end of the year
BRUSSELS — EU leaders agreed Tuesday to donate at least 100 million doses of COVID-19 vaccines to poorer nations by the end of the year as supplies steadily rise across Europe.
Gathered in Brussels for a two-day summit, the 27 leaders backed a text in which they pledge to continue efforts “to increase global vaccine production capacities in order to meet global needs.”
Leaders also called “for work to be stepped up to ensure global equitable access to COVID-19 vaccines” and reiterated their support for the U.N.-backed COVAX program. COVAX aims to ensure equitable access to COVID-19 shots for low-and middle-income countries.
The program suffered a major setback last week when its biggest supplier, the Serum Institute of India, announced it would likely not export any more vaccines until the end of the year due to the COVID-19 crisis on the subcontinent.
Leaders acknowledged that vaccination has finally picked up across their continent following a painfully slow start compared with the successful drives in the U.S., Britain and Israel. European Commission president Ursula von der Leyen presented data to the leaders suggesting that 300 million doses will have been delivered in the region by the end of May, with about 46% of the adult population in the bloc of 450 million getting at least a first dose of vaccine.
But as vaccination campaigns continue to progress in the Western world, poorer countries are struggling to acquire supplies. During a health summit in Rome last week, Italian Premier Mario Draghi said that nearly 1.5 billion vaccine doses have been administered in over 180 countries worldwide. Yet only 0.3% were in low-income countries, while richer countries administered around 85%.
In addition to the donation of shots, leaders pledged to help countries in need to develop vaccine production locally.
It was unclear which vaccines from the EU’s portfolio would be donated. Coronavirus vaccines authorized by the European Medicines Agency, the bloc’s drug regulator, include Pfizer, Moderna, AstraZeneca and Johnson & Johnson.
The agreement came after the U.S. said earlier this month it will share an additional 20 million doses of COVID-19 vaccines with the world on top of a prior commitment to share about 60 million doses of AstraZeneca vaccine.
The EU plans to have the trans-border passes up and running by July 1. They will be delivered to EU residents who can prove they have been vaccinated, as well as those who tested negative for the virus or have proof they recovered from COVID-19, and should serve to avoid quarantines and more testing upon arrival.
———
Raf Casert contributed to this story.
———
Follow AP’s pandemic coverage at:
https://apnews.com/hub/coronavirus-pandemic
https://apnews.com/hub/coronavirus-vaccine
https://apnews.com/UnderstandingtheOutbreak
